nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B1—breast cancer	0.22	0.542	CbGaD
Pioglitazone—PTGS1—breast cancer	0.0819	0.202	CbGaD
Pioglitazone—CYP2D6—breast cancer	0.0558	0.138	CbGaD
Pioglitazone—CYP3A4—breast cancer	0.0478	0.118	CbGaD
Pioglitazone—SLCO1B3—Paclitaxel—breast cancer	0.0282	0.0785	CbGbCtD
Pioglitazone—SLCO1B3—Docetaxel—breast cancer	0.0204	0.0567	CbGbCtD
Pioglitazone—CYP2C9—Anastrozole—breast cancer	0.0186	0.0519	CbGbCtD
Pioglitazone—CYP2C8—Lapatinib—breast cancer	0.0178	0.0496	CbGbCtD
Pioglitazone—SLCO1B1—Irinotecan—breast cancer	0.0162	0.0451	CbGbCtD
Pioglitazone—CYP2C19—Lapatinib—breast cancer	0.015	0.0416	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—breast cancer	0.0147	0.041	CbGbCtD
Pioglitazone—CYP3A4—Exemestane—breast cancer	0.0143	0.0398	CbGbCtD
Pioglitazone—CYP2C9—Idarubicin—breast cancer	0.0141	0.0393	CbGbCtD
Pioglitazone—CYP2C8—Raloxifene—breast cancer	0.0135	0.0376	CbGbCtD
Pioglitazone—CYP2D6—Idarubicin—breast cancer	0.0129	0.0359	CbGbCtD
Pioglitazone—CYP3A4—Letrozole—breast cancer	0.0122	0.0338	CbGbCtD
Pioglitazone—CYP3A4—Anastrozole—breast cancer	0.0108	0.0302	CbGbCtD
Pioglitazone—CYP3A4—Toremifene—breast cancer	0.00992	0.0276	CbGbCtD
Pioglitazone—CYP3A4—Fulvestrant—breast cancer	0.00922	0.0256	CbGbCtD
Pioglitazone—CYP2C8—Tamoxifen—breast cancer	0.00893	0.0248	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—breast cancer	0.00858	0.0239	CbGbCtD
Pioglitazone—CYP3A4—Thiotepa—breast cancer	0.00822	0.0229	CbGbCtD
Pioglitazone—CYP2C9—Capecitabine—breast cancer	0.00774	0.0215	CbGbCtD
Pioglitazone—CYP3A4—Ixabepilone—breast cancer	0.00752	0.0209	CbGbCtD
Pioglitazone—CYP2C19—Tamoxifen—breast cancer	0.00749	0.0208	CbGbCtD
Pioglitazone—CYP3A4—Lapatinib—breast cancer	0.00723	0.0201	CbGbCtD
Pioglitazone—CYP2C8—Paclitaxel—breast cancer	0.00695	0.0193	CbGbCtD
Pioglitazone—CYP2C8—Fluorouracil—breast cancer	0.00658	0.0183	CbGbCtD
Pioglitazone—CYP2D6—Vinorelbine—breast cancer	0.00631	0.0176	CbGbCtD
Pioglitazone—CYP2C9—Tamoxifen—breast cancer	0.00623	0.0173	CbGbCtD
Pioglitazone—CYP2D6—Tamoxifen—breast cancer	0.0057	0.0158	CbGbCtD
Pioglitazone—CYP3A4—Raloxifene—breast cancer	0.00548	0.0152	CbGbCtD
Pioglitazone—CYP2C9—Paclitaxel—breast cancer	0.00485	0.0135	CbGbCtD
Pioglitazone—CYP2C9—Fluorouracil—breast cancer	0.00459	0.0128	CbGbCtD
Pioglitazone—CYP3A4—Vinorelbine—breast cancer	0.00401	0.0112	CbGbCtD
Pioglitazone—CYP2D6—Vinblastine—breast cancer	0.00389	0.0108	CbGbCtD
Pioglitazone—CYP3A4—Tamoxifen—breast cancer	0.00362	0.0101	CbGbCtD
Pioglitazone—CYP3A4—Mitoxantrone—breast cancer	0.00353	0.00983	CbGbCtD
Pioglitazone—CYP3A4—Paclitaxel—breast cancer	0.00282	0.00784	CbGbCtD
Pioglitazone—CYP3A4—Irinotecan—breast cancer	0.00278	0.00774	CbGbCtD
Pioglitazone—CYP3A4—Vinblastine—breast cancer	0.00247	0.00688	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—breast cancer	0.00239	0.00665	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—breast cancer	0.00204	0.00567	CbGbCtD
Pioglitazone—PPARG—Topotecan—Irinotecan—breast cancer	0.00161	1	CbGdCrCtD
Pioglitazone—CYP3A4—Doxorubicin—breast cancer	0.00152	0.00423	CbGbCtD
Pioglitazone—Rosiglitazone—SLCO1B1—breast cancer	0.00135	0.551	CrCbGaD
Pioglitazone—SLCO1B1—mammary gland—breast cancer	0.000924	0.0673	CbGeAlD
Pioglitazone—PPARG—mammary gland—breast cancer	0.000797	0.058	CbGeAlD
Pioglitazone—SLCO1B3—pituitary gland—breast cancer	0.000722	0.0526	CbGeAlD
Pioglitazone—PPARG—nipple—breast cancer	0.000659	0.048	CbGeAlD
Pioglitazone—SLCO1B3—endocrine gland—breast cancer	0.000559	0.0407	CbGeAlD
Pioglitazone—PPARG—embryo—breast cancer	0.000544	0.0396	CbGeAlD
Pioglitazone—CYP2C8—mammary gland—breast cancer	0.000525	0.0382	CbGeAlD
Pioglitazone—Rosiglitazone—PTGS1—breast cancer	0.000505	0.205	CrCbGaD
Pioglitazone—CYP2C9—mammary gland—breast cancer	0.000467	0.034	CbGeAlD
Pioglitazone—PPARG—epithelium—breast cancer	0.000444	0.0323	CbGeAlD
Pioglitazone—PPARG—skin of body—breast cancer	0.000422	0.0307	CbGeAlD
Pioglitazone—SLCO1B1—female reproductive system—breast cancer	0.000382	0.0278	CbGeAlD
Pioglitazone—PPARG—uterus—breast cancer	0.000367	0.0267	CbGeAlD
Pioglitazone—PPARG—adipose tissue—breast cancer	0.000359	0.0261	CbGeAlD
Pioglitazone—PTGS1—nipple—breast cancer	0.000352	0.0257	CbGeAlD
Pioglitazone—Rosiglitazone—CYP2D6—breast cancer	0.000344	0.14	CrCbGaD
Pioglitazone—PPARG—female reproductive system—breast cancer	0.00033	0.024	CbGeAlD
Pioglitazone—SLCO1B1—endocrine gland—breast cancer	0.000324	0.0235	CbGeAlD
Pioglitazone—PPARG—adrenal gland—breast cancer	0.000322	0.0234	CbGeAlD
Pioglitazone—PPARG—bone marrow—breast cancer	0.000311	0.0227	CbGeAlD
Pioglitazone—PPARG—female gonad—breast cancer	0.0003	0.0218	CbGeAlD
Pioglitazone—PPARG—endocrine gland—breast cancer	0.000279	0.0203	CbGeAlD
Pioglitazone—CYP2C8—endometrium—breast cancer	0.000262	0.0191	CbGeAlD
Pioglitazone—Rosiglitazone—ALB—breast cancer	0.000257	0.105	CrCbGaD
Pioglitazone—CYP2C8—pituitary gland—breast cancer	0.000237	0.0173	CbGeAlD
Pioglitazone—PTGS1—epithelium—breast cancer	0.000237	0.0173	CbGeAlD
Pioglitazone—PTGS1—skin of body—breast cancer	0.000226	0.0164	CbGeAlD
Pioglitazone—CYP2C8—female reproductive system—breast cancer	0.000217	0.0158	CbGeAlD
Pioglitazone—PTGS1—endometrium—breast cancer	0.000213	0.0155	CbGeAlD
Pioglitazone—CYP2C19—endocrine gland—breast cancer	0.000211	0.0153	CbGeAlD
Pioglitazone—PTGS1—uterus—breast cancer	0.000196	0.0143	CbGeAlD
Pioglitazone—CYP2C9—female reproductive system—breast cancer	0.000193	0.0141	CbGeAlD
Pioglitazone—PPARG—lymph node—breast cancer	0.000193	0.014	CbGeAlD
Pioglitazone—PTGS1—pituitary gland—breast cancer	0.000193	0.014	CbGeAlD
Pioglitazone—PTGS1—adipose tissue—breast cancer	0.000192	0.014	CbGeAlD
Pioglitazone—CYP2C8—endocrine gland—breast cancer	0.000184	0.0134	CbGeAlD
Pioglitazone—PTGS1—female reproductive system—breast cancer	0.000176	0.0128	CbGeAlD
Pioglitazone—PTGS1—adrenal gland—breast cancer	0.000172	0.0125	CbGeAlD
Pioglitazone—CYP2C9—endocrine gland—breast cancer	0.000163	0.0119	CbGeAlD
Pioglitazone—PTGS1—female gonad—breast cancer	0.00016	0.0117	CbGeAlD
Pioglitazone—PTGS1—endocrine gland—breast cancer	0.000149	0.0109	CbGeAlD
Pioglitazone—CYP3A4—female reproductive system—breast cancer	0.000147	0.0107	CbGeAlD
Pioglitazone—CYP2D6—female reproductive system—breast cancer	0.000145	0.0105	CbGeAlD
Pioglitazone—CYP2D6—female gonad—breast cancer	0.000132	0.0096	CbGeAlD
Pioglitazone—CYP3A4—endocrine gland—breast cancer	0.000125	0.00907	CbGeAlD
Pioglitazone—CYP2D6—endocrine gland—breast cancer	0.000123	0.00892	CbGeAlD
Pioglitazone—PTGS1—lymph node—breast cancer	0.000103	0.00751	CbGeAlD
Pioglitazone—Flatulence—Capecitabine—breast cancer	4.51e-05	0.000317	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—breast cancer	4.51e-05	0.000316	CcSEcCtD
Pioglitazone—Feeling abnormal—Gemcitabine—breast cancer	4.48e-05	0.000315	CcSEcCtD
Pioglitazone—Dizziness—Vinorelbine—breast cancer	4.48e-05	0.000314	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—breast cancer	4.48e-05	0.000314	CcSEcCtD
Pioglitazone—Nervous system disorder—Paclitaxel—breast cancer	4.47e-05	0.000314	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—breast cancer	4.46e-05	0.000313	CcSEcCtD
Pioglitazone—Urticaria—Mitoxantrone—breast cancer	4.44e-05	0.000311	CcSEcCtD
Pioglitazone—Back pain—Capecitabine—breast cancer	4.43e-05	0.000311	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—breast cancer	4.43e-05	0.000311	CcSEcCtD
Pioglitazone—Diarrhoea—Thiotepa—breast cancer	4.42e-05	0.000311	CcSEcCtD
Pioglitazone—Skin disorder—Paclitaxel—breast cancer	4.42e-05	0.000311	CcSEcCtD
Pioglitazone—Feeling abnormal—Fluorouracil—breast cancer	4.41e-05	0.000309	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—breast cancer	4.4e-05	0.000309	CcSEcCtD
Pioglitazone—Muscle spasms—Capecitabine—breast cancer	4.4e-05	0.000309	CcSEcCtD
Pioglitazone—Hyperhidrosis—Paclitaxel—breast cancer	4.4e-05	0.000309	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—breast cancer	4.37e-05	0.000307	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—breast cancer	4.36e-05	0.000306	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—breast cancer	4.36e-05	0.000306	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—breast cancer	4.32e-05	0.000304	CcSEcCtD
Pioglitazone—Dizziness—Thiotepa—breast cancer	4.28e-05	0.0003	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—breast cancer	4.26e-05	0.000299	CcSEcCtD
Pioglitazone—Ill-defined disorder—Capecitabine—breast cancer	4.25e-05	0.000298	CcSEcCtD
Pioglitazone—Urticaria—Fluorouracil—breast cancer	4.25e-05	0.000298	CcSEcCtD
Pioglitazone—Headache—Vinorelbine—breast cancer	4.24e-05	0.000298	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—breast cancer	4.24e-05	0.000297	CcSEcCtD
Pioglitazone—Anaemia—Capecitabine—breast cancer	4.23e-05	0.000297	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—breast cancer	4.18e-05	0.000294	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—breast cancer	4.17e-05	0.000293	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—breast cancer	4.16e-05	0.000292	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.15e-05	0.000291	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—breast cancer	4.14e-05	0.000291	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—breast cancer	4.13e-05	0.00029	CcSEcCtD
Pioglitazone—Malaise—Capecitabine—breast cancer	4.13e-05	0.00029	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—breast cancer	4.13e-05	0.00029	CcSEcCtD
Pioglitazone—Insomnia—Paclitaxel—breast cancer	4.12e-05	0.000289	CcSEcCtD
Pioglitazone—Vertigo—Capecitabine—breast cancer	4.11e-05	0.000289	CcSEcCtD
Pioglitazone—Hypersensitivity—Mitoxantrone—breast cancer	4.11e-05	0.000289	CcSEcCtD
Pioglitazone—Hypersensitivity—Irinotecan—breast cancer	4.11e-05	0.000289	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—breast cancer	4.08e-05	0.000287	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—breast cancer	4.08e-05	0.000287	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—breast cancer	4.08e-05	0.000287	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—breast cancer	4.07e-05	0.000286	CcSEcCtD
Pioglitazone—Dyspnoea—Paclitaxel—breast cancer	4.06e-05	0.000285	CcSEcCtD
Pioglitazone—Headache—Thiotepa—breast cancer	4.05e-05	0.000284	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—breast cancer	4.03e-05	0.000283	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—breast cancer	4.03e-05	0.000283	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—breast cancer	4.03e-05	0.000283	CcSEcCtD
Pioglitazone—Asthenia—Mitoxantrone—breast cancer	4.01e-05	0.000281	CcSEcCtD
Pioglitazone—Asthenia—Irinotecan—breast cancer	4.01e-05	0.000281	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4e-05	0.000281	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—breast cancer	3.97e-05	0.000279	CcSEcCtD
Pioglitazone—Hypertension—Capecitabine—breast cancer	3.95e-05	0.000278	CcSEcCtD
Pioglitazone—Hypersensitivity—Fluorouracil—breast cancer	3.94e-05	0.000277	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—breast cancer	3.94e-05	0.000276	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Paclitaxel—breast cancer	3.93e-05	0.000276	CcSEcCtD
Pioglitazone—Fatigue—Paclitaxel—breast cancer	3.93e-05	0.000276	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—breast cancer	3.92e-05	0.000275	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—breast cancer	3.91e-05	0.000275	CcSEcCtD
Pioglitazone—Asthenia—Gemcitabine—breast cancer	3.9e-05	0.000274	CcSEcCtD
Pioglitazone—Chest pain—Capecitabine—breast cancer	3.9e-05	0.000274	CcSEcCtD
Pioglitazone—Arthralgia—Capecitabine—breast cancer	3.9e-05	0.000274	CcSEcCtD
Pioglitazone—Myalgia—Capecitabine—breast cancer	3.9e-05	0.000274	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—breast cancer	3.89e-05	0.000273	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—breast cancer	3.89e-05	0.000273	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	3.87e-05	0.000272	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—breast cancer	3.87e-05	0.000272	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—breast cancer	3.86e-05	0.000271	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—breast cancer	3.86e-05	0.000271	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—breast cancer	3.86e-05	0.000271	CcSEcCtD
Pioglitazone—Discomfort—Capecitabine—breast cancer	3.85e-05	0.00027	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—breast cancer	3.84e-05	0.00027	CcSEcCtD
Pioglitazone—Infection—Docetaxel—breast cancer	3.84e-05	0.000269	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—breast cancer	3.83e-05	0.000269	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—breast cancer	3.83e-05	0.000269	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—breast cancer	3.82e-05	0.000268	CcSEcCtD
Pioglitazone—Diarrhoea—Irinotecan—breast cancer	3.82e-05	0.000268	CcSEcCtD
Pioglitazone—Diarrhoea—Mitoxantrone—breast cancer	3.82e-05	0.000268	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—breast cancer	3.79e-05	0.000266	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—breast cancer	3.78e-05	0.000265	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—breast cancer	3.78e-05	0.000265	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—breast cancer	3.77e-05	0.000265	CcSEcCtD
Pioglitazone—Feeling abnormal—Paclitaxel—breast cancer	3.75e-05	0.000263	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—breast cancer	3.75e-05	0.000263	CcSEcCtD
Pioglitazone—Oedema—Capecitabine—breast cancer	3.74e-05	0.000262	CcSEcCtD
Pioglitazone—Diarrhoea—Gemcitabine—breast cancer	3.72e-05	0.000261	CcSEcCtD
Pioglitazone—Infection—Capecitabine—breast cancer	3.71e-05	0.000261	CcSEcCtD
Pioglitazone—Dizziness—Irinotecan—breast cancer	3.69e-05	0.000259	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—breast cancer	3.67e-05	0.000258	CcSEcCtD
Pioglitazone—Nervous system disorder—Capecitabine—breast cancer	3.67e-05	0.000257	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—breast cancer	3.66e-05	0.000257	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—breast cancer	3.66e-05	0.000257	CcSEcCtD
Pioglitazone—Diarrhoea—Fluorouracil—breast cancer	3.66e-05	0.000257	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—breast cancer	3.65e-05	0.000256	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—breast cancer	3.64e-05	0.000255	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—breast cancer	3.63e-05	0.000255	CcSEcCtD
Pioglitazone—Skin disorder—Capecitabine—breast cancer	3.63e-05	0.000255	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—breast cancer	3.62e-05	0.000254	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—breast cancer	3.62e-05	0.000254	CcSEcCtD
Pioglitazone—Urticaria—Paclitaxel—breast cancer	3.62e-05	0.000254	CcSEcCtD
Pioglitazone—Hyperhidrosis—Capecitabine—breast cancer	3.61e-05	0.000254	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—breast cancer	3.61e-05	0.000253	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—breast cancer	3.6e-05	0.000253	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—breast cancer	3.6e-05	0.000253	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—breast cancer	3.59e-05	0.000252	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—breast cancer	3.54e-05	0.000249	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—breast cancer	3.54e-05	0.000248	CcSEcCtD
Pioglitazone—Dizziness—Fluorouracil—breast cancer	3.54e-05	0.000248	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—breast cancer	3.53e-05	0.000248	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—breast cancer	3.53e-05	0.000248	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—breast cancer	3.52e-05	0.000247	CcSEcCtD
Pioglitazone—Headache—Mitoxantrone—breast cancer	3.5e-05	0.000246	CcSEcCtD
Pioglitazone—Headache—Irinotecan—breast cancer	3.5e-05	0.000246	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—breast cancer	3.49e-05	0.000245	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—breast cancer	3.44e-05	0.000242	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—breast cancer	3.42e-05	0.00024	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—breast cancer	3.41e-05	0.000239	CcSEcCtD
Pioglitazone—Headache—Gemcitabine—breast cancer	3.41e-05	0.000239	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.41e-05	0.000239	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—breast cancer	3.4e-05	0.000239	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—breast cancer	3.39e-05	0.000238	CcSEcCtD
Pioglitazone—Insomnia—Capecitabine—breast cancer	3.38e-05	0.000237	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—breast cancer	3.37e-05	0.000237	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—breast cancer	3.37e-05	0.000236	CcSEcCtD
Pioglitazone—Hypersensitivity—Paclitaxel—breast cancer	3.36e-05	0.000236	CcSEcCtD
Pioglitazone—Headache—Fluorouracil—breast cancer	3.35e-05	0.000235	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—breast cancer	3.35e-05	0.000235	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—breast cancer	3.34e-05	0.000235	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—breast cancer	3.33e-05	0.000234	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—breast cancer	3.33e-05	0.000234	CcSEcCtD
Pioglitazone—Dyspnoea—Capecitabine—breast cancer	3.33e-05	0.000234	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—breast cancer	3.33e-05	0.000234	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—breast cancer	3.32e-05	0.000233	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—breast cancer	3.31e-05	0.000232	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—breast cancer	3.3e-05	0.000232	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—breast cancer	3.3e-05	0.000232	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—breast cancer	3.27e-05	0.000229	CcSEcCtD
Pioglitazone—Asthenia—Paclitaxel—breast cancer	3.27e-05	0.000229	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Capecitabine—breast cancer	3.23e-05	0.000227	CcSEcCtD
Pioglitazone—Fatigue—Capecitabine—breast cancer	3.22e-05	0.000226	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—breast cancer	3.19e-05	0.000224	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—breast cancer	3.18e-05	0.000223	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—breast cancer	3.17e-05	0.000222	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—breast cancer	3.16e-05	0.000222	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—breast cancer	3.15e-05	0.000221	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—breast cancer	3.15e-05	0.000221	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—breast cancer	3.14e-05	0.000221	CcSEcCtD
Pioglitazone—Diarrhoea—Paclitaxel—breast cancer	3.12e-05	0.000219	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—breast cancer	3.09e-05	0.000217	CcSEcCtD
Pioglitazone—Feeling abnormal—Capecitabine—breast cancer	3.08e-05	0.000216	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—breast cancer	3.07e-05	0.000216	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—breast cancer	3.07e-05	0.000215	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—breast cancer	3.06e-05	0.000215	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—breast cancer	3.06e-05	0.000215	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—breast cancer	3.06e-05	0.000215	CcSEcCtD
Pioglitazone—Dizziness—Paclitaxel—breast cancer	3.01e-05	0.000211	CcSEcCtD
Pioglitazone—Urticaria—Capecitabine—breast cancer	2.97e-05	0.000208	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—breast cancer	2.96e-05	0.000208	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—breast cancer	2.95e-05	0.000207	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—breast cancer	2.95e-05	0.000207	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—breast cancer	2.91e-05	0.000204	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—breast cancer	2.9e-05	0.000204	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—breast cancer	2.9e-05	0.000204	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—breast cancer	2.9e-05	0.000204	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.88e-05	0.000202	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—breast cancer	2.88e-05	0.000202	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—breast cancer	2.87e-05	0.000201	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—breast cancer	2.87e-05	0.000201	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—breast cancer	2.86e-05	0.0002	CcSEcCtD
Pioglitazone—Headache—Paclitaxel—breast cancer	2.85e-05	0.0002	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—breast cancer	2.84e-05	0.0002	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—breast cancer	2.84e-05	0.000199	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—breast cancer	2.78e-05	0.000195	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—breast cancer	2.77e-05	0.000194	CcSEcCtD
Pioglitazone—Infection—Methotrexate—breast cancer	2.76e-05	0.000194	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—breast cancer	2.75e-05	0.000193	CcSEcCtD
Pioglitazone—Hypersensitivity—Capecitabine—breast cancer	2.75e-05	0.000193	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—breast cancer	2.74e-05	0.000192	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—breast cancer	2.73e-05	0.000192	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—breast cancer	2.73e-05	0.000192	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—breast cancer	2.72e-05	0.000191	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—breast cancer	2.72e-05	0.000191	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—breast cancer	2.72e-05	0.000191	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—breast cancer	2.7e-05	0.00019	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.7e-05	0.000189	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—breast cancer	2.69e-05	0.000189	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—breast cancer	2.68e-05	0.000188	CcSEcCtD
Pioglitazone—Asthenia—Capecitabine—breast cancer	2.68e-05	0.000188	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—breast cancer	2.66e-05	0.000187	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—breast cancer	2.65e-05	0.000186	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—breast cancer	2.64e-05	0.000185	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—breast cancer	2.6e-05	0.000183	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—breast cancer	2.6e-05	0.000183	CcSEcCtD
Pioglitazone—Infection—Epirubicin—breast cancer	2.59e-05	0.000182	CcSEcCtD
Pioglitazone—Diarrhoea—Capecitabine—breast cancer	2.56e-05	0.00018	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—breast cancer	2.55e-05	0.000179	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—breast cancer	2.55e-05	0.000179	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—breast cancer	2.55e-05	0.000179	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.53e-05	0.000178	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—breast cancer	2.53e-05	0.000178	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—breast cancer	2.52e-05	0.000177	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—breast cancer	2.52e-05	0.000177	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—breast cancer	2.51e-05	0.000176	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—breast cancer	2.51e-05	0.000176	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—breast cancer	2.51e-05	0.000176	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.5e-05	0.000175	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—breast cancer	2.48e-05	0.000174	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—breast cancer	2.48e-05	0.000174	CcSEcCtD
Pioglitazone—Dizziness—Capecitabine—breast cancer	2.47e-05	0.000174	CcSEcCtD
Pioglitazone—Headache—Docetaxel—breast cancer	2.42e-05	0.00017	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—breast cancer	2.41e-05	0.000169	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—breast cancer	2.41e-05	0.000169	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—breast cancer	2.4e-05	0.000169	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—breast cancer	2.4e-05	0.000168	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—breast cancer	2.39e-05	0.000168	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.37e-05	0.000167	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—breast cancer	2.36e-05	0.000166	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—breast cancer	2.35e-05	0.000165	CcSEcCtD
Pioglitazone—Headache—Capecitabine—breast cancer	2.34e-05	0.000164	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—breast cancer	2.34e-05	0.000164	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—breast cancer	2.33e-05	0.000164	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—breast cancer	2.32e-05	0.000163	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—breast cancer	2.29e-05	0.000161	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—breast cancer	2.25e-05	0.000158	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—breast cancer	2.24e-05	0.000158	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—breast cancer	2.21e-05	0.000155	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.19e-05	0.000154	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—breast cancer	2.18e-05	0.000153	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—breast cancer	2.15e-05	0.000151	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—breast cancer	2.15e-05	0.000151	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.08e-05	0.000146	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—breast cancer	2.08e-05	0.000146	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—breast cancer	2.07e-05	0.000145	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—breast cancer	2.05e-05	0.000144	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—breast cancer	2e-05	0.00014	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—breast cancer	1.99e-05	0.000139	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—breast cancer	1.92e-05	0.000135	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—breast cancer	1.91e-05	0.000134	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—breast cancer	1.9e-05	0.000134	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—breast cancer	1.87e-05	0.000131	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—breast cancer	1.84e-05	0.000129	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—breast cancer	1.78e-05	0.000125	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—breast cancer	1.77e-05	0.000125	CcSEcCtD
Pioglitazone—Headache—Methotrexate—breast cancer	1.74e-05	0.000122	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—breast cancer	1.73e-05	0.000121	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—breast cancer	1.72e-05	0.000121	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—breast cancer	1.65e-05	0.000116	CcSEcCtD
Pioglitazone—Headache—Epirubicin—breast cancer	1.63e-05	0.000115	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—breast cancer	1.59e-05	0.000112	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—breast cancer	1.51e-05	0.000106	CcSEcCtD
Pioglitazone—CYP3A4—Metabolism—ABCC1—breast cancer	3.43e-06	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMMR—breast cancer	3.43e-06	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA3—breast cancer	3.43e-06	4.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ACHE—breast cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—breast cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.43e-06	4.58e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—breast cancer	3.41e-06	4.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP3A4—breast cancer	3.41e-06	4.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.39e-06	4.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA2—breast cancer	3.39e-06	4.53e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CAV1—breast cancer	3.38e-06	4.53e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—breast cancer	3.37e-06	4.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1B1—breast cancer	3.35e-06	4.49e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—breast cancer	3.34e-06	4.47e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.32e-06	4.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HSP90AA1—breast cancer	3.29e-06	4.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FASN—breast cancer	3.29e-06	4.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BCHE—breast cancer	3.27e-06	4.38e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP17A1—breast cancer	3.27e-06	4.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP17A1—breast cancer	3.24e-06	4.34e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS1—breast cancer	3.24e-06	4.33e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO1—breast cancer	3.24e-06	4.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—breast cancer	3.23e-06	4.33e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.23e-06	4.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS1—breast cancer	3.21e-06	4.3e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO1—breast cancer	3.21e-06	4.3e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—breast cancer	3.2e-06	4.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NCOA1—breast cancer	3.2e-06	4.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.2e-06	4.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.16e-06	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—STK11—breast cancer	3.15e-06	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP19A1—breast cancer	3.15e-06	4.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2D6—breast cancer	3.15e-06	4.21e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA9—breast cancer	3.13e-06	4.19e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA4—breast cancer	3.13e-06	4.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NQO1—breast cancer	3.12e-06	4.18e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC2A1—breast cancer	3.12e-06	4.18e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA2—breast cancer	3.12e-06	4.17e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—breast cancer	3.11e-06	4.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA2—breast cancer	3.09e-06	4.13e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—breast cancer	3.08e-06	4.12e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.06e-06	4.09e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA2—breast cancer	3.05e-06	4.09e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX2—breast cancer	3.05e-06	4.09e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—breast cancer	3.05e-06	4.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP3A4—breast cancer	3.05e-06	4.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.03e-06	4.05e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FASN—breast cancer	3.02e-06	4.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SULT1A1—breast cancer	3.02e-06	4.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX4—breast cancer	3.02e-06	4.04e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BCHE—breast cancer	3.01e-06	4.03e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—breast cancer	3.01e-06	4.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FASN—breast cancer	3e-06	4.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1B1—breast cancer	2.99e-06	4.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BCHE—breast cancer	2.98e-06	3.99e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—breast cancer	2.97e-06	3.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.96e-06	3.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—breast cancer	2.95e-06	3.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—IDH1—breast cancer	2.95e-06	3.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA1—breast cancer	2.95e-06	3.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.94e-06	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—COMT—breast cancer	2.93e-06	3.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—breast cancer	2.92e-06	3.9e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAT2—breast cancer	2.91e-06	3.9e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—breast cancer	2.91e-06	3.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HMOX1—breast cancer	2.88e-06	3.85e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—breast cancer	2.88e-06	3.85e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NQO1—breast cancer	2.87e-06	3.84e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC2A1—breast cancer	2.87e-06	3.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ITPR1—breast cancer	2.87e-06	3.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA1—breast cancer	2.86e-06	3.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC2A1—breast cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NQO1—breast cancer	2.85e-06	3.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—STK11—breast cancer	2.81e-06	3.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP19A1—breast cancer	2.81e-06	3.77e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP3A4—breast cancer	2.8e-06	3.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.79e-06	3.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP3A4—breast cancer	2.78e-06	3.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.76e-06	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—breast cancer	2.76e-06	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1B1—breast cancer	2.75e-06	3.68e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1B1—breast cancer	2.73e-06	3.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMS—breast cancer	2.71e-06	3.63e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—breast cancer	2.71e-06	3.63e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.7e-06	3.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.68e-06	3.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NCOR1—breast cancer	2.68e-06	3.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—breast cancer	2.68e-06	3.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—breast cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.64e-06	3.53e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—breast cancer	2.63e-06	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA1—breast cancer	2.63e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—COMT—breast cancer	2.62e-06	3.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—breast cancer	2.6e-06	3.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA1—breast cancer	2.6e-06	3.48e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—STK11—breast cancer	2.59e-06	3.46e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP19A1—breast cancer	2.59e-06	3.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HMOX1—breast cancer	2.57e-06	3.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—breast cancer	2.57e-06	3.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—STK11—breast cancer	2.57e-06	3.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP19A1—breast cancer	2.57e-06	3.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ITPR1—breast cancer	2.56e-06	3.43e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—breast cancer	2.56e-06	3.42e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MED12—breast cancer	2.56e-06	3.42e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DPYD—breast cancer	2.56e-06	3.42e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—breast cancer	2.54e-06	3.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ERCC2—breast cancer	2.52e-06	3.37e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALDOA—breast cancer	2.52e-06	3.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—breast cancer	2.47e-06	3.3e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA3—breast cancer	2.44e-06	3.27e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A2—breast cancer	2.42e-06	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMS—breast cancer	2.42e-06	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—breast cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—COMT—breast cancer	2.41e-06	3.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—breast cancer	2.4e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOR1—breast cancer	2.39e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.39e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—breast cancer	2.39e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—COMT—breast cancer	2.39e-06	3.19e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CPT1A—breast cancer	2.38e-06	3.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG2—breast cancer	2.38e-06	3.18e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTR—breast cancer	2.38e-06	3.18e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—breast cancer	2.37e-06	3.18e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—breast cancer	2.37e-06	3.17e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HMOX1—breast cancer	2.36e-06	3.16e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—breast cancer	2.36e-06	3.16e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ITPR1—breast cancer	2.36e-06	3.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HMOX1—breast cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—breast cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ITPR1—breast cancer	2.34e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPGDS—breast cancer	2.33e-06	3.12e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HBA1—breast cancer	2.32e-06	3.1e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—breast cancer	2.29e-06	3.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—breast cancer	2.29e-06	3.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—breast cancer	2.27e-06	3.04e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—breast cancer	2.27e-06	3.03e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACHE—breast cancer	2.26e-06	3.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—breast cancer	2.26e-06	3.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ERCC2—breast cancer	2.25e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—breast cancer	2.25e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMS—breast cancer	2.23e-06	2.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMS—breast cancer	2.21e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOR1—breast cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—breast cancer	2.2e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAV1—breast cancer	2.19e-06	2.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOR1—breast cancer	2.18e-06	2.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.18e-06	2.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—breast cancer	2.18e-06	2.92e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—breast cancer	2.16e-06	2.89e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP17A1—breast cancer	2.14e-06	2.86e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO1—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS1—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—breast cancer	2.12e-06	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—breast cancer	2.11e-06	2.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—breast cancer	2.09e-06	2.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—breast cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2D6—breast cancer	2.08e-06	2.78e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ERCC2—breast cancer	2.07e-06	2.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—breast cancer	2.07e-06	2.77e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—breast cancer	2.06e-06	2.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ERCC2—breast cancer	2.05e-06	2.74e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—breast cancer	2.04e-06	2.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA2—breast cancer	2.04e-06	2.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—breast cancer	1.99e-06	2.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FASN—breast cancer	1.98e-06	2.64e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BCHE—breast cancer	1.97e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—breast cancer	1.97e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAV1—breast cancer	1.95e-06	2.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—breast cancer	1.95e-06	2.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—breast cancer	1.94e-06	2.6e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—breast cancer	1.93e-06	2.58e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NQO1—breast cancer	1.88e-06	2.51e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A1—breast cancer	1.88e-06	2.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.86e-06	2.49e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1B1—breast cancer	1.8e-06	2.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAV1—breast cancer	1.79e-06	2.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAV1—breast cancer	1.78e-06	2.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—breast cancer	1.78e-06	2.38e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.77e-06	2.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—breast cancer	1.75e-06	2.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—breast cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA1—breast cancer	1.72e-06	2.3e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.7e-06	2.27e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—STK11—breast cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP19A1—breast cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—breast cancer	1.68e-06	2.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—breast cancer	1.65e-06	2.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—breast cancer	1.63e-06	2.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—breast cancer	1.62e-06	2.17e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.62e-06	2.17e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—COMT—breast cancer	1.57e-06	2.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—breast cancer	1.57e-06	2.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—breast cancer	1.56e-06	2.09e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMOX1—breast cancer	1.54e-06	2.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—breast cancer	1.54e-06	2.06e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ITPR1—breast cancer	1.54e-06	2.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—breast cancer	1.53e-06	2.04e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—breast cancer	1.51e-06	2.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—breast cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—breast cancer	1.48e-06	1.97e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMS—breast cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—breast cancer	1.44e-06	1.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—breast cancer	1.44e-06	1.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOR1—breast cancer	1.44e-06	1.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.44e-06	1.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.44e-06	1.92e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—breast cancer	1.42e-06	1.91e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—breast cancer	1.42e-06	1.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—breast cancer	1.41e-06	1.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—breast cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.36e-06	1.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—breast cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—breast cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ERCC2—breast cancer	1.35e-06	1.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—breast cancer	1.35e-06	1.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—breast cancer	1.35e-06	1.8e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—breast cancer	1.32e-06	1.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—breast cancer	1.32e-06	1.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—breast cancer	1.27e-06	1.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.25e-06	1.68e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—breast cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—breast cancer	1.24e-06	1.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—breast cancer	1.23e-06	1.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—breast cancer	1.18e-06	1.57e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—breast cancer	1.18e-06	1.57e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAV1—breast cancer	1.17e-06	1.57e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—breast cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—breast cancer	1.07e-06	1.44e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.07e-06	1.43e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—breast cancer	9.4e-07	1.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—breast cancer	9.3e-07	1.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—breast cancer	9.27e-07	1.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—breast cancer	8.87e-07	1.19e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—breast cancer	8.3e-07	1.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—breast cancer	8.19e-07	1.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—breast cancer	8.11e-07	1.09e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—breast cancer	7.64e-07	1.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—breast cancer	7.6e-07	1.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—breast cancer	7.57e-07	1.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—breast cancer	7.08e-07	9.47e-06	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—breast cancer	6.78e-07	9.07e-06	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—breast cancer	6.24e-07	8.34e-06	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—breast cancer	6.18e-07	8.27e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—breast cancer	4.99e-07	6.68e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—breast cancer	4.08e-07	5.46e-06	CbGpPWpGaD
